These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 24036282)
1. Binding sites and hydrophobic pockets in Human Thioredoxin 1 determined by normal mode analysis. Philot EA; Perahia D; Braz AS; Costa MG; Scott LP J Struct Biol; 2013 Nov; 184(2):293-300. PubMed ID: 24036282 [TBL] [Abstract][Full Text] [Related]
2. Binding of phenothiazines into allosteric hydrophobic pocket of human thioredoxin 1. Philot EA; da Mata Lopes D; de Souza AT; Braz AS; Nantes IL; Rodrigues T; Perahia D; Miteva MA; Scott LP Eur Biophys J; 2016 Apr; 45(3):279-86. PubMed ID: 26820562 [TBL] [Abstract][Full Text] [Related]
3. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator. Hui WQ; Cheng Q; Liu TY; Ouyang Q J Mol Model; 2016 Apr; 22(4):90. PubMed ID: 27021209 [TBL] [Abstract][Full Text] [Related]
4. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study. Gadhe CG; Balupuri A; Cho SJ J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117 [TBL] [Abstract][Full Text] [Related]
5. LOX1 inhibition with small molecules. Gousiadou C; Kouskoumvekaki I J Mol Graph Model; 2016 Jan; 63():99-109. PubMed ID: 26722761 [TBL] [Abstract][Full Text] [Related]
6. Toward understanding the molecular basis for chemical allosteric modulator design. Wang Q; Zheng M; Huang Z; Liu X; Zhou H; Chen Y; Shi T; Zhang J J Mol Graph Model; 2012 Sep; 38():324-33. PubMed ID: 23085171 [TBL] [Abstract][Full Text] [Related]
7. Identification of potential inhibitors of Fasciola gigantica thioredoxin1: computational screening, molecular dynamics simulation, and binding free energy studies. Shukla R; Shukla H; Kalita P; Sonkar A; Pandey T; Singh DB; Kumar A; Tripathi T J Biomol Struct Dyn; 2018 Jun; 36(8):2147-2162. PubMed ID: 28627969 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow. Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662 [TBL] [Abstract][Full Text] [Related]
9. Crystal structures of two functionally different thioredoxins in spinach chloroplasts. Capitani G; Marković-Housley Z; DelVal G; Morris M; Jansonius JN; Schürmann P J Mol Biol; 2000 Sep; 302(1):135-54. PubMed ID: 10964566 [TBL] [Abstract][Full Text] [Related]
10. Computational approaches elucidate the allosteric mechanism of human aromatase inhibition: a novel possible route to Small-molecule regulation of CYP450s activities? Sgrignani J; Bon M; Colombo G; Magistrato A J Chem Inf Model; 2014 Oct; 54(10):2856-68. PubMed ID: 25178092 [TBL] [Abstract][Full Text] [Related]
11. Elucidation of allosteric inhibition mechanism of 2-Cys human peroxiredoxin by molecular modeling. Kim M; Lee KW; Cho AE J Chem Inf Model; 2012 Dec; 52(12):3278-83. PubMed ID: 23194275 [TBL] [Abstract][Full Text] [Related]
12. Binding of modulators to mouse and human multidrug resistance P-glycoprotein. A computational study. Jara GE; Vera DM; Pierini AB J Mol Graph Model; 2013 Nov; 46():10-21. PubMed ID: 24095875 [TBL] [Abstract][Full Text] [Related]
13. Allosteric regulation of PKCθ: understanding multistep phosphorylation and priming by ligands in AGC kinases. Seco J; Ferrer-Costa C; Campanera JM; Soliva R; Barril X Proteins; 2012 Jan; 80(1):269-80. PubMed ID: 22072623 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of thioredoxin A1 from Corynebacterium pseudotuberculosis by polyanions and flavonoids. Eberle RJ; Kawai LA; de Moraes FR; Olivier D; do Amaral MS; Tasic L; Arni RK; Coronado MA Int J Biol Macromol; 2018 Oct; 117():1066-1073. PubMed ID: 29885395 [TBL] [Abstract][Full Text] [Related]
15. Protein-protein interactions at an enzyme-substrate interface: characterization of transient reaction intermediates throughout a full catalytic cycle of Escherichia coli thioredoxin reductase. Negri A; Rodríguez-Larrea D; Marco E; Jiménez-Ruiz A; Sánchez-Ruiz JM; Gago F Proteins; 2010 Jan; 78(1):36-51. PubMed ID: 19585660 [TBL] [Abstract][Full Text] [Related]
16. New in silico insights into the inhibition of RNAP II by α-amanitin and the protective effect mediated by effective antidotes. Garcia J; Carvalho AT; Dourado DF; Baptista P; de Lourdes Bastos M; Carvalho F J Mol Graph Model; 2014 Jun; 51():120-7. PubMed ID: 24879323 [TBL] [Abstract][Full Text] [Related]
17. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design. Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of T-cell protein tyrosine phosphatase (TCPTP) activation by mitoxantrone. Ylilauri M; Mattila E; Nurminen EM; Käpylä J; Niinivehmas SP; Määttä JA; Pentikäinen U; Ivaska J; Pentikäinen OT Biochim Biophys Acta; 2013 Oct; 1834(10):1988-97. PubMed ID: 23856547 [TBL] [Abstract][Full Text] [Related]
19. Ligand aligning method for molecular docking: alignment of property-weighted vectors. Joung JY; Nam KY; Cho KH; No KT J Chem Inf Model; 2012 Apr; 52(4):984-95. PubMed ID: 22471323 [TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulations of thioredoxin with S-glutathiolated cysteine-73. Han S Biochem Biophys Res Commun; 2007 Oct; 362(2):532-7. PubMed ID: 17716625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]